People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

SOUTH SAN FRANCISCO, Calif., August 12, 2025--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop ...

An acromegaly diagnosis can feel overwhelming, and because its a rare disorder, it may seem like youre alone in your symptoms and treatment journey. Your doctor may focus on your hormone levels, but ...

Learn how acromegaly can affect eyesight, including causes of vision changes, common symptoms like side vision loss, and ...

NEEDHAM, Mass., March 22, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology ...

A new Clinical Practice Guideline (CPG) for the diagnosis and treatment of acromegaly, a rare condition caused by excess growth hormone in the blood, has been issued. The Endocrine Society today ...